Loading...
•
Jun 30, 2022
Bruker Q2 2022 Earnings Report
Bruker's Q2 2022 financial results were announced, featuring revenue growth and strategic investments.
Key Takeaways
Bruker reported a 3.1% year-over-year increase in revenue for Q2 2022, with organic revenue growth of 8.8%. GAAP EPS was $0.33, and non-GAAP EPS was $0.45, a 2.3% increase year-over-year. The company is maintaining its FY 2022 guidance for high single-digit organic revenue growth, non-GAAP operating profit margin expansion, and non-GAAP EPS increase.
Q2 2022 reported revenue growth of 3.1% year-over-year, with organic revenue growth of 8.8%.
Q2 2022 GAAP EPS was $0.33, and non-GAAP EPS was $0.45, up 2.3% year-over-year.
Bruker Scientific Instruments (BSI) revenues increased 2.9% year-over-year, with organic revenue growth of 8.1%.
Bruker Energy & Supercon Technologies (BEST) revenues increased 4.6% year-over-year, with organic growth of 15.1%.
Bruker
Bruker
Bruker Revenue by Segment
Bruker Revenue by Geographic Location
Revenue by Segment
BEST Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Bruker is maintaining its FY 2022 organic revenue growth guidance, while lowering reported revenue growth guidance to account for stronger foreign currency translation headwinds. Bruker continues to expect FY 2022 non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year, from 19.4% in FY 2021. Bruker continues to expect FY 2022 non-GAAP EPS of $2.29 to $2.33, a 9% to 11% increase year-over-year.
Positive Outlook
- Organic growth of 7% to 9%.
- M&A contributions of approximately 1.5%.
- Non-GAAP operating margin expansion of 30 bps to 60 bps year-over-year.
- FY 2022 non-GAAP EPS of $2.29 to $2.33.
- 9% to 11% increase year-over-year in non-GAAP EPS.
Challenges Ahead
- Foreign currency translation headwinds of approximately -6%.
- Lowering reported revenue growth guidance.
- Impact of supply chain challenges.
- Impact of geopolitical tensions.
- Continued volatility in the capital markets.